

A Decade of Heroes Gala
On Oct 14 2017, We celebrated 10 years of Hep B Free. We were honored to have among our speakers US Senator Mazie Hirono, Board of Equalization Member Fiona Ma, State Assemblymember David Chiu and many others. It was a fun-filled and amazing night to celebrate progress and charge forward. If you're interested, more pictures are posted on our Facebook.


Thank you for a Successful Summit
Thank you to everyone who attended our 3rd annual educational summit on Vaccine Preventable Cancers, this past Friday, September 15. We are grateful to have such amazing partners for this year's summit, the San Francisco Immunization Coalition, and the Prevent Cancer Foundation. We hope everyone had an amazing and educational experience! Click here for presentations.


San Francisco Hep B Free – Bay Area
It has been a truly exciting journey to make our expansion into San Mateo County possible this year, under our new name San Francisco Hep B Free-Bay Area. It is with the support of so many leaders within San Mateo County that we have been able to make this effort possible. We held our press conference this morning in Burlingame to announce or official expansion, and our efforts in replicating the successful model San Francisco Hep B Free has created over the past decade into


Chinatown Resource Fair
Always great having a rush of people coming to your booth to get free blood pressure checks while learning about hepatitis B. Over 70 people stopped over, asked questions and shared their stories. #EndHepatitisB#BFree At DAs Office 13th Chinatown Resource Fair.


Dynavax Announces FDA Approval
A new milestone in Hep B prevention has been achieved. Yesterday, on November 9th, the FDA approved HEPLISAV-B, the first new hepatitis B vaccine in the United States in more than 25 years and the only two-dose hepatitis B vaccine for adults. Dynavax expects to commercially launch HEPLISAV-B in the United States in the first quarter of 2018. This 2 shot vaccine could greatly increase successful vaccination rates given almost half of adults fail to complete the hepatitis B vac